Stone Clearance Rates Following Extracorporeal Shock Wave Lithotripsy: Comparative Efficacy in Lower Pole and Other Renal Locations: A Prospective Observational Study.
ESWL achieved high short-term stone clearance rates across different intrarenal stone locations, with comparable outcomes observed between lower pole and non-lower pole calculi in this cohort.
Abstract
Introduction: Extracorporeal shock wave lithotripsy (ESWL) remains a widely used non-invasive treatment for renal calculi, yet stone clearance in lower pole stones has been debated due to anatomical and gravitational factors.
Methods: A prospective observational study was conducted at the Sindh Institute of Urology and Transplantation (SIUT), Karachi, between June and December 2022. A total of 105 patients with solitary renal stones measuring 4–20 mm was included. Patients were categorized by stone location: lower pole (Group 1), mid pole (Group 2), pelvis (Group 3), and upper pole (Group 4). All underwent ESWL on a Storz Modulith SLX lithotripter under a standardized protocol, with a maximum of three sessions. Stone-free status was assessed radiologically three weeks after treatment. Statistical analyses included chi-square and t-tests, with significance at p < 0.05.
Results: The mean age of participants was 41.45 ± 12.32 years; 55.2% were male. The mean stone size was 12.3 ± 3.3 mm. The overall stone-free rate was 86.7%. Clearance was achieved in 85.7% of lower pole stones (Group 1), 84.6% in mid pole (Group 2), 87.2% in pelvis (Group 3), and 90.9% in upper pole (Group 4), with no statistically significant differences among groups (p = 0.967). Complications were minimal and self‑limited.
Conclusion: ESWL achieved high short-term stone clearance rates across different intrarenal stone locations, with comparable outcomes observed between lower pole and non-lower pole calculi in this cohort. Larger multicenter studies incorporating anatomical and radiological predictors with longer follow-up are needed to validate these findings and optimize patient selection.
Objective: To compare the effects of extracorporeal shock wave lithotripsy (ESWL) in comparison with high-density renal stones (1000 Hounsfield units) with respect to stone-free rate, auxiliary procedures, and complications.
Methods: A total of one hundred and two consecutive adult patients having renal stones at most...
Rizwan Ullah, Asad Shamsher, Muhammad Yasir Mujtaba, Hassamullah Khan, Isar Ahmad, Muhammad Afnan· Journal of Carcinogenesis· 0 citations
OBJECTIVE
Extracorporeal shock wave lithotripsy (ESWL) is a first-line treatment for renal stones, yet outcomes are variable. This study aimed to identify predictors of stone clearance, complications, and number of treatment sessions in patients undergoing ESWL for kidney stones.
PATIENTS AND METHODS
We conducted a r...
Mazen Karama, F. Noman, A. Karama et al.· Archivio Italiano di Urologi...· 0 citations
ABSTRACT Objectives: To compare outcomes of extracorporeal shock wave lithotripsy (ESWL) and retrograde intrarenal surgery (RIRS) for renal stones measuring 1-2 cm, including stone clearance, hospital stay, hematuria, sepsis, postoperative pain, and retreatment. Methodology: Six months, single-center, open-label, paral...
Muhammad Waqas Arshad, A. Javed, Shafeullah Ahadi et al.· Pakistan Journal of Medical...· 0 citations
Mini-PCNL may provide superior stone clearance and fewer retreatments than ESWL for pediatric renal stones <2 cm, but current evidence remains limited by study quality and heterogeneity.
R. A. Lantemona, Ananda Firdaus, Ferdian Harum Istikanto et al.· Glosains Jurnal Sains Global...· 0 citations
RIRS demonstrates comparable efficacy and safety for single and multiple renal stones, supporting its use on a viable treatment option in patients with stone multiplicity, and larger adequately powered studies are warranted to determine whether smaller between-group differences exist.
Ahmed M. Abdel Gawad, T. Abouelgreed, M. Rehan et al.· Archivio Italiano di Urologi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.